| Dawn Belt Davis, MD, PHD | |
|
University Of Wisconsin Hospital And Clinics, 600 Highland Ave. Room H4/576 5148, Madison, WI 53792-3284 | |
| (608) 263-5010 | |
| (608) 264-4660 |
| Full Name | Dawn Belt Davis |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 21 Years |
| Location | University Of Wisconsin Hospital And Clinics, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164480513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 48459 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Wi Hospitals & Clinics Authority | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Wisconsin Medical Foundation Inc | 6608785464 | 2164 |
News Archive
Nearly one in five people suffers from the insidious and often devastating problem of chronic pain.
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida.
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
› Verified 1 days ago
| Entity Name | University Of Wisconsin Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
Nearly one in five people suffers from the insidious and often devastating problem of chronic pain.
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida.
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Belt Davis, MD, PHD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Dawn Belt Davis, MD, PHD University Of Wisconsin Hospital And Clinics, 600 Highland Ave. Room H4/576 5148, Madison, WI 53792-3284 Ph: (608) 263-5010 |
News Archive
Nearly one in five people suffers from the insidious and often devastating problem of chronic pain.
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida.
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
› Verified 1 days ago
Prof. Marvin Lyle Birnbaum, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3330 University Ave, Suite 300, Madison, WI 53705 Phone: 608-263-9641 Fax: 608-265-4429 | |
Yingyu Gao, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Sam Joseph Lubner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-265-1700 | |
Randy S Heidel, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20 S Park St, Madison, WI 53715 Phone: 608-287-2250 Fax: 608-287-2438 | |
Benjamin Kleiber, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Dean & St. Mary's Outpatient Center, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-2956 | |
N Thomas Casper, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3102 Meriter Way, Madison, WI 53719 Phone: 608-417-8800 | |
Philip Tepper Cohen, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5154 Juneau Rd, Madison, WI 53705 Phone: 608-441-2512 Fax: 608-441-2512 |